Literature DB >> 16288025

The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells.

Hagen Kulbe1, Thorsten Hagemann, Piotr W Szlosarek, Frances R Balkwill, Julia L Wilson.   

Abstract

Epithelial ovarian cancer cells express the chemokine receptor, CXCR4, which may be associated with increased survival and metastatic potential, but the regulation of this receptor is not understood. The inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) is found in ovarian cancer biopsies and is associated with increased tumor grade. In this report, we show that CXCR4 expression on human epithelial ovarian cancer cells is associated with, and can be modulated by, TNF-alpha. Ovarian cancer cells with high endogenous expression of TNF-alpha expressed higher levels of CXCR4 mRNA and protein than cells with low TNF-alpha expression. Stimulation of ovarian cancer cell lines and primary epithelial cancer cells with TNF-alpha resulted in increased CXCR4 mRNA and protein. The TNF-alpha-stimulated increase in CXCR4 mRNA was due partly to de novo synthesis, and up-regulation of CXCR4 cell surface protein increased migration to the CXCR4 ligand CXCL12. CXCR4 mRNA and protein was down-regulated by anti-TNF-alpha antibody or by targeting TNF-alpha mRNA using RNAi. TNF-alpha stimulation activated components of the nuclear factor kappaB pathway, and overexpression of the inhibitor of kappaB also reduced CXCR4 expression. Coculture of macrophages with ovarian cancer cells also resulted in cancer cell up-regulation of CXCR4 mRNA in a TNF-alpha-dependent manner. Finally, there was a correlation between the levels of TNF-alpha and CXCR4 mRNA in clinical biopsies of ovarian cancer, and TNF-alpha protein was expressed in CXCR4-positive tumor cells. TNF-alpha is a critical mediator of tumor promotion in a number of experimental cancers. Our data suggest that one mechanism may be through nuclear factor kappaB-dependent induction of CXCR4.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288025     DOI: 10.1158/0008-5472.CAN-05-0957

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  63 in total

1.  Characterization of the cytokine expression profiles of the aorta and liver of young tumor necrosis factor alpha mutant mice.

Authors:  Yanrong Sun; Miao Yin; Liang Zhang; Jie Pan
Journal:  Mol Cell Biochem       Date:  2012-03-10       Impact factor: 3.396

2.  RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration.

Authors:  Neveen Said; Marta Sanchez-Carbayo; Steven C Smith; Dan Theodorescu
Journal:  J Clin Invest       Date:  2012-03-12       Impact factor: 14.808

Review 3.  Phosphorylation of mammalian cytochrome c and cytochrome c oxidase in the regulation of cell destiny: respiration, apoptosis, and human disease.

Authors:  Maik Hüttemann; Icksoo Lee; Lawrence I Grossman; Jeffrey W Doan; Thomas H Sanderson
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 4.  Tumor necrosis factor and cancer, buddies or foes?

Authors:  Xia Wang; Yong Lin
Journal:  Acta Pharmacol Sin       Date:  2008-11       Impact factor: 6.150

5.  Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization.

Authors:  Selene Nunez-Cruz; Phyllis A Gimotty; Matthew W Guerra; Denise C Connolly; You-Qiang Wu; Robert A DeAngelis; John D Lambris; George Coukos; Nathalie Scholler
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

Review 6.  Cancer-related inflammation.

Authors:  Juliana Candido; Thorsten Hagemann
Journal:  J Clin Immunol       Date:  2012-12-09       Impact factor: 8.317

7.  Inhibitory effects of simvastatin on staphylococcus aureus lipoteichoic acid-induced inflammation in human alveolar macrophages.

Authors:  Ben-Quan Wu; Jin-Mei Luo; Yan-Hong Wang; Yun-Feng Shi; Hui Liu; Jun-Hui Ba; Tian-Tuo Zhang
Journal:  Clin Exp Med       Date:  2013-03-03       Impact factor: 3.984

Review 8.  Fatigue and sleep during cancer and chemotherapy: translational rodent models.

Authors:  Maria Ray; Laura Q Rogers; Rita A Trammell; Linda A Toth
Journal:  Comp Med       Date:  2008-06       Impact factor: 0.982

9.  Vesnarinone downregulates CXCR4 expression via upregulation of Krüppel-like factor 2 in oral cancer cells.

Authors:  Daisuke Uchida; Tomitaro Onoue; Nasima-Mila Begum; Nobuyuki Kuribayashi; Yoshifumi Tomizuka; Tetsuya Tamatani; Hirokazu Nagai; Youji Miyamoto
Journal:  Mol Cancer       Date:  2009-08-12       Impact factor: 27.401

Review 10.  TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion.

Authors:  Y Wu; B P Zhou
Journal:  Br J Cancer       Date:  2010-01-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.